These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8639954)

  • 1. Regulatory framework and requirements for managing risks associated with veterinary biological products in Africa: present systems and future needs.
    Sylla D; Rweyemamu MM; Palya VJ
    Rev Sci Tech; 1995 Dec; 14(4):1171-84. PubMed ID: 8639954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of risk assessment to veterinary biologicals: the perspective of the animal health industry.
    Folkers C; Draayer HA; Verschueren C
    Rev Sci Tech; 1995 Dec; 14(4):1207-16. PubMed ID: 8639957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of international and regional organisations in the regulation of veterinary biologicals.
    Blancou J; Truszczynski M
    Rev Sci Tech; 1995 Dec; 14(4):1193-206. PubMed ID: 8639956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience with veterinary vaccines in warm climates.
    Tulasne JJ; Lefèvre PC; Blancou J
    Dev Biol Stand; 1996; 87():33-42. PubMed ID: 8854000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A reassessment of the dual vaccine against rinderpest and contagious bovine pleuropneumonia.
    Jeggo MH; Wardley RC; Corteyn AH
    Vet Rec; 1987 Feb; 120(6):131-5. PubMed ID: 3300010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contagious bovine pleuropneumonia vaccines: the need for improvements.
    Rweyemamu MM; Litamoi J; Palya V; Sylla D
    Rev Sci Tech; 1995 Sep; 14(3):593-601. PubMed ID: 8593393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologicals: test procedures available to assess components and products, with limitations.
    Lee AM
    Rev Sci Tech; 1995 Dec; 14(4):1073-82. PubMed ID: 8639947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stabilization of rinderpest vaccine by modification of the lyophilization process.
    House JA; Mariner JC
    Dev Biol Stand; 1996; 87():235-44. PubMed ID: 8854023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Quality control of the vaccines and cold chain during the national vaccination campaigns].
    Couacy-Hymann E; Kodjo A; Ouattara M; Kanga K; Diawara S; Domenech J
    Rev Elev Med Vet Pays Trop; 1992; 45(2):129-33. PubMed ID: 1338738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Present systems and future needs for risk assessments of biologicals: the perspective of the regulator in the People's Republic of China.
    Xia Y; Zhang Z; Li M
    Rev Sci Tech; 1995 Dec; 14(4):1185-91. PubMed ID: 8639955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Who Expert Committee on Biological Standardization.
    World Health Organization
    World Health Organ Tech Rep Ser; 2004; 926():1-109. PubMed ID: 15918537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratories which produce veterinary vaccines.
    Randall DC
    Rev Sci Tech; 1998 Aug; 17(2):568-77. PubMed ID: 9713896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Authorities and procedures for licensing veterinary biological products in the United States.
    Espeseth DA; Myers TJ
    Adv Vet Med; 1999; 41():585-93. PubMed ID: 9890045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk analysis for the importation of veterinary biologicals into the United States of America.
    Roth HJ; Gay CG; Espeseth DA
    Rev Sci Tech; 1995 Dec; 14(4):1061-72. PubMed ID: 8639946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk analysis for veterinary biologicals released into the environment.
    Silva SV; Samagh BS; Morley RS
    Rev Sci Tech; 1995 Dec; 14(4):1043-59. PubMed ID: 8639945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of viral vaccines for veterinary use.
    van Gelder P; Makoschey B
    Berl Munch Tierarztl Wochenschr; 2012; 125(3-4):103-9. PubMed ID: 22515027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WHO Expert Committee on Biological Standardization. Forty-sixth Report.
    World Health Organ Tech Rep Ser; 1998; 872():i-vii, 1-90. PubMed ID: 9615608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European regulations relevant to the marketing and use of fish vaccines.
    Lee A
    Dev Biol Stand; 1997; 90():341-6. PubMed ID: 9270862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. European Pharmacopoeia (EP), USDA and MAFF standards--will they ever be harmonised under the VICH umbrella?
    Castle P
    Dev Biol (Basel); 2005; 121():227-34. PubMed ID: 15962485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of introducing exotic disease through importation of animals and animal products.
    Metcalf HE; McElvaine MD
    Rev Sci Tech; 1995 Dec; 14(4):951-6. PubMed ID: 8639963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.